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The natural retinoprotectant 
chrysophanol attenuated 
photoreceptor cell apoptosis 
in an N-methyl-N-nitrosourea-
induced mouse model of retinal 
degenaration
Fan-Li Lin1, Cheng-Hui Lin2, Jau-Der Ho3, Jing-Lun Yen1, Hung-Ming Chang4, 
George C. Y. Chiou5, Yu-Wen Cheng2,* & George Hsiao1,*
Retinitis pigmentosa (RP) is an inherited photoreceptor-degenerative disease, and neuronal 
degeneration in RP is exacerbated by glial activation. Cassia seed (Jue-ming-zi) is a traditional herbal 
medicine commonly used to treat ocular diseases in Asia. In this report, we investigated the retina-
protective effect of chrysophanol, an active component of Cassia seed, in an N-methyl-N-nitrosourea 
(MNU)-induced mouse model of RP. We determined that chrysophanol inhibited the functional and 
morphological features of MNU-induced retinal degeneration using scotopic electroretinography (ERG), 
optical coherence tomography (OCT), and immunohistochemistry analysis of R/G opsin and rhodopsin. 
Furthermore, TUNEL assays revealed that chrysophanol attenuated MNU-induced photoreceptor 
cell apoptosis and inhibited the expression of the apoptosis-associated proteins PARP, Bax, and 
caspase-3. In addition, chrysophanol ameliorated reactive gliosis, as demonstrated by a decrease in 
GFAP immunolabeling, and suppressed the activation of matrix metalloproteinase (MMP)-9-mediated 
gelatinolysis. In vitro studies indicated that chrysophanol inhibited lipopolysaccharide (LPS)-induced 
iNOS and COX-2 expression in the BV2 mouse microglia cell line and inhibited MMP-9 activation in 
primary microglia. Our results demonstrate that chrysophanol provided neuroprotective effects and 
inhibited glial activation, suggesting that chrysophanol might have therapeutic value for the treatment 
of human RP and other retinopathies.
Retinitis pigmentosa (RP) refers to a heterogeneous group of inherited retinal degenerative diseases that are 
characterized by progressive photoreceptor cell death. Genetic aberrations are directly implicated in the apoptosis 
of rod photoreceptors and the development of night blindness. Neurotrophic factor depletion and increases in 
oxidative stress following massive rod cell death can also induce apoptosis in cone photoreceptors, thereby pro-
moting the loss of bright and color vision. Modes of glial activation, including microglia recruitment and reactive 
gliosis, are also involved in the pathogenesis of RP in humans and in mouse models1–3. A recent study demon-
strated that microglia infiltrate the outer nuclear layer during early stages of retinal degeneration3. In addition 
to removing debris and apoptotic neurons, dysfunctional microglia execute neuronal cell death via a process of 
phagoptosis4,5. RP commonly results in vision loss, especially in patients who develop RP in adolescence or 
1Graduate Institute of Medical Sciences and Department of Pharmacology, School of Medicine, College of Medicine, 
Taipei Medical University, Taipei, Taiwan. 2School of Pharmacy, College of Pharmacy, Taipei Medical University, 
Taipei, Taiwan. 3Department of Ophthalmology, Taipei Medical University Hospital, Taipei, Taiwan. 4Department 
of Anatomy, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. 5Department of 
Neuroscience and Experimental Therapeutics and Institute of Ocular Pharmacology, College of Medicine, Texas A&M 
Health Science Center, College Station, TX, USA. *These authors contributed equally to this work. Correspondence 
and requests for materials should be addressed to G.H. (email: geohsiao@tmu.edu.tw)
received: 01 July 2016
Accepted: 15 December 2016
Published: 23 January 2017
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7:41086 | DOI: 10.1038/srep41086
infancy. Therefore, visual acuity is disrupted during the early stages of RP, resulting in significantly higher health-
care costs and disability-adjusted life years for these patients6. Although RP affects millions of individuals world-
wide, there are no therapies currently approved for the treatment of this disease.
Cassia seed (Jue-ming-zi, Cassia toro) is a traditional herbal medicine widely used in Asia to treat eye complications7,8. 
Previous studies have demonstrated that Cassia seed provides clinical benefits to patients with ophthal-
mic conditions, such as glaucoma and cataracts9,10. Chrysophanol, an active anthraquinone isolated from 
Cassia seed, exhibits various pharmacological effects, including anti-oxidative11, anti-hyperlipidemia12, and 
anti-inflammatory effects13,14. However, few studies have evaluated the protective effects of chrysophanol in the 
context of ocular diseases. In the present study, we investigated the retina-protective effects of chrysophanol in 
an N-methyl-N-nitrosourea (MNU)-induced mouse model of RP in vivo15. Similar to the mechanism of cell 
death in human RP, MNU selectively induces cell death in photoreceptor cells via apoptosis16. Therefore, the 
MNU-induced mouse model of RP is a reliable and appropriate approach to investigate the neuroprotective 
effects and mechanisms mediated by bioactive compounds, such as chrysophanol, in RP.
Chrysophanol prevented the functional and morphological features of MNU-induced photoreceptor apop-
tosis and retinal degeneration, and ameliorated glial activation. These findings suggest that the primary active 
component of Cassia seed, chrysophanol, has the potential to inhibit RP progression and prevent retinal injury. 
However, the mechanisms underlying this phenomenon, as well as the toxicity and long-term effects of chrysoph-
anol, require further investigation.
Results
N-methyl-N-nitrosourea (MNU)-induced photoreceptor cell loss and retinal dysfunction in a 
dose-dependent manner. As shown in Fig. 1a, OCT images revealed that MNU-induced degeneration 
of the outer nuclear layer (ONL) in the retinas of C57BL/6 mice in a dose-dependent manner 7 days after it was 
administered. At day 7, photoreceptor degeneration resulting from photoreceptor cell loss was clearly observed 
in the MNU-treated group (60 mg/kg), and the total retinal thickness was significantly reduced. In addition, 
Figure 1. Morphological and functional defects in mouse retina 7 days after treatment with various doses 
of MNU. (a) OCT images revealed retinal ONL degeneration 7 days after the mice were treated with various 
doses of MNU. Retinal detachment (asterisk) was observed in the group treated with MNU (70 mg/kg).  
(b) Scotopic electroretinogram (ERG) responses of a- and b-waves elicited by light at an intensity of 19.1 cd · s/m2 
were recorded at the same time point. CTRL: control; GCL: ganglion cell layer; IPL: inner plexiform layer; INL: 
inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer; IS: inner segment; OS: outer segment; 
RPE: retinal pigment epithelium.
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scotopic electroretinogram (ERG) responses of the a-wave and b-wave amplitude were strongly reduced in the 
MNU-treated group (60 mg/kg) compared to control mice (Fig. 1b). Consistently, delayed implicit time (time 
to peak) of a-wave and b-wave was found in MNU-treated group. These findings suggested that a significant 
loss in retinal function had occurred. Retinal detachment was observed in the 70 mg/kg MNU-treated group 
compared with the 60 mg/kg MNU-treated group. Therefore, MNU was used at a dose of 60 mg/kg in subsequent 
experiments.
Chrysophanol treatment restored retinal function of elctroretinogram (ERG) in MNU-exposed 
photoreceptors. To assess whether chrysophanol treatment can restore photoreceptor cell function, we 
measured scotopic responses of electroretinogram (ERG) in MNU-exposed retinas. A standard scotopic ERG is 
composed of an a-wave and a b-wave17. The a-wave reflects the integrity of the combined rod and cone response, 
and the b-wave reflects the response of ON bipolar cells and the function of Muller cells18. On day 7, the a-wave 
amplitude and b-wave amplitude were strongly reduced in MNU-exposed retinas (60 mg/kg; a-wave, 20.0 ± 4.0 μ V; 
b-wave, 72.3 ± 18.3 μ V) compared with the control group (a-wave, 158.2 ± 11.2 μ V; b-wave, 361.3 ± 25.5 μ V). 
Chrysophanol (50 mg/kg) treatment rescued MNU-induced retinal dysfunction and increased ERG responses 
(a-wave, 62.0 ± 8.2 μ V; b-wave, 180.1 ± 14.7 μ V) (Fig. 2a,b). Moreover, delayed implicit time was found in 
MNU-exposed group (a-wave, 29.0 ± 1.8 milliseconds (ms); b-wave, 115.5 ± 7.5 ms) compared with the control 
group (a-wave, 23.3 ± 0.6 ms; b-wave, 79.7 ± 3.0 ms). Chrysophanol treatment protected against MNU-induced 
retinal dysfunction and improved ERG responses (a-wave, 26.4 ± 1.2 ms; b-wave, 94.9 ± 4.2 ms) (Fig. 2a,c).
Chrysophanol inhibited MNU-induced photoreceptor degeneration. Representative OCT images 
of control retinas and MNU-exposed retinas treated with chrysophanol (50 mg/kg) or the vehicle control were 
Figure 2. Chrysophanol preserved MNU-injured photoreceptor function on day 7. (a) Representative 
scotopic ERG responses from control mice (blue curve), and MNU-exposed mice treated with the vehicle 
control (red curve) or chrysophanol (green curve). (b,c) Quantification of the average amplitudes and implicit 
time (time to peak) from control mice (n = 7), and MNU-exposed mice treated with the vehicle control (n = 5) 
or chrysophanol (n = 11). The ERG a-waves were negative, and the a-wave amplitudes are presented as the 
absolute value. The data were presented as the mean ± SEM. CTRL: control. #p < 0.05 compared with the 
control group treated with vehicle, ##p < 0.001 compared with the control group treated with vehicle, *p < 0.01 
compared with MNU-exposed group treated with vehicle.
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shown in Fig. 3a. OCT images revealed that the cumulative thickness of the ONL, the inner segments (IS), and the 
outer segments (OS) layer (32.6 ± 3.9 μ m) was significantly reduced 7 days after the administration of MNU com-
pared with the control retinas (89.5 ± 2.5 μ m). This effect was prevented by chrysophanol treatment (47.3 ± 5.0 μ m). 
Consistent with these findings, the total thickness of MNU-exposed retinas (162.3 ± 6.5 μ m) significantly 
decreased 7 days after the administration of MNU compared with the control group (229.5 ± 4.2 μ m). This effect 
was significantly protected in retinas treated with chrysophanol (184.9 ± 5.4 μ m) (Fig. 3a,b). DAPI staining 
demonstrated that the normal morphology of control retinas was characterized by three layers: the ganglion cell 
layer (GCL), the inner nuclear layer (INL), and the ONL (Fig. 3c). Compared with the control group, the num-
ber of rows of photoreceptor nuclei in the ONL was significantly reduced in MNU-exposed retinas (5.8 ± 0.6) 
Figure 3. Chrysophanol attenuated MNU-induced photoreceptor degeneration on day 7. (a) OCT was 
used to evaluate changes in retinal thickness in control mice (n = 7) and in mice treated with the vehicle control 
(n = 6) or chrysophanol (n = 8) 7 days after the administration of MNU (60 mg/kg). (b) Quantification of the 
thickness of the separated layer using InSight XL software. (c) The arrangement of nuclei in the GCL, INL and 
ONL in DAPI-counterstained retina sections. (d) Quantification of the number of photoreceptor nuclei rows in 
the ONL. The data are presented as the mean ± SEM. CTRL: control; N: number of animals in each group; GCL: 
ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer 
nuclear layer; IS: inner segment; OS: outer segment; RPE: retinal pigmented epithelium. #p < 0.001 compared 
with the control group treated with vehicle, *p < 0.05 compared with the MNU-exposed group treated with 
vehicle, **p < 0.01 compared with the MNU-exposed group treated with vehicle, ***p < 0.001 compared with 
the MNU-treated group treated with vehicle.
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compared to control group (9.8 ± 0.2), and this reduction was markedly prevented by chrysophanol treatment 
(8.1 ± 0.8; Fig. 3c,d). DAPI staining of photoreceptor nuclei demonstrated similar results acquired from OCT.
To further evaluate the protective effect of chrysophanol on photoreceptor cell loss, we stained vertical retinal 
sections with antibodies against rhodopsin and red/green opsin to selectively label rod and cone photoreceptors, 
respectively19. The rod OS in MNU-treated retinas exhibited an abnormal, truncated pattern compared with con-
trol retinas (Fig. 4a), and chrysophanol treatment rescued the defects in OS organization and length. In addition 
to the protection of rods, we observed that chrysophanol inhibited MNU-induced damage to cone photore-
ceptors (Fig. 4b). Opsin immunostaining revealed that the amount and morphology of the MNU-exposed cone 
OS was disrupted compared with the well-arranged pattern observed in the control group, and this defect was res-
cued by chrysophanol treatment. Therefore, chrysophanol protected both rod and cone cells from MNU-induced 
morphological changes.
Chrysophanol inhibited MNU-induced photoreceptor cell apoptosis and the expression of 
apoptosis-associated proteins. The signals of TUNEL were found in the ONL after 12 hours expo-
sure of MNU (60 mg/kg). Peak levels of apoptosis were observed on day 1, and the number of apoptotic 
cells gradually decreased on days 3 and 7 (Fig. 5a). Chrysophanol treatment significantly reduced the num-
ber of TUNEL-labeled cells in the ONL (Fig. 5b) 1 day after MNU-exposure. These results suggested that chrys-
ophanol treatment blocked early photoreceptor cell apoptosis in MNU-exposed retinas.
To identify the mechanism underlying the anti-apoptotic effect of chrysophanol, we examined the expres-
sion of PARP, caspase-3, Bax, and phosphorylated c-Jun in MNU-exposed retinas (Fig. 6). Pro-PARP and 
cleaved-PARP levels increased 2.3- and 2.7-fold, respectively, in MNU-exposed retinas compared with 
control retinas. And pro-PARP and cleaved-PARP levels significantly decreased 1.5- and 1.9-fold in the 
chrysophanol-treated MNU-exposed group compared with the MNU-exposed group, respectively. In addi-
tion, Bax levels were 2.7-fold higher in MNU-exposed retinas compared with control retinas, whereas Bax levels 
decreased 1.3-fold in the chrysophanol-treated MNU-exposed retinas compared with MNU-exposed retinas. 
Compared with control retinas, caspase-3 levels increased 1.8-fold in MNU-exposed retinas, and chrysophanol 
significantly reduced caspase-3 levels by 1.9-fold compared with the MNU-exposed retinas. In addition, phos-
phorylated c-Jun levels increased 3.1-fold in MNU-exposed retinas compared with control retinas and decreased 
1.9-fold in the chrysophanol-treated group compared with the MNU-exposed group. Together, these results 
revealed that the anti-apoptotic effect of chrysophanol on photoreceptor cells exposed to MNU was mediated by 
the down-regulation of PARP, Bax, caspase-3, and phosphorylated c-Jun levels.
Figure 4. Chrysophanol rescued MNU-induced cone and rod degeneration on day 7. (a) The rod 
photoreceptors (labeled by rhodopsin in green) primarily localized to the OS. (b) The cone photoreceptors 
(labeled by red/green opsin in green) primarily localized to the OS. CTRL: control; INL: inner nuclear layer; 
ONL: outer nuclear layer; IS: inner segment; OS: outer segment.
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Chrysophanol inhibited glial fibrillary acidic protein (GFAP) expression and MMP-9 activation 
in MNU-exposed retinas. In the resting phase, GFAP localization is primarily restricted to the nerve fiber 
layer (NFL) and the GCL. Immunofluorescence assays demonstrated that GFAP was progressively up-regulated 
in a time-dependent manner in mice exposed to MNU (60 mg/kg) (Fig. 7a). These GFAP-positive processes were 
twisted and extended from GCL to INL. GFAP protein levels strongly increased and extended in MNU-treated 
group on day 7, and this effect was significantly inhibited by chrysophanol (Fig. 7b,c). The expression and acti-
vation of matrix metalloproteinase-9 (MMP-9) has previously been observed in retinopathies, and this effect 
is directly associated with an increase in GFAP expression20. Therefore, we evaluated MMP-9 activation in our 
MNU-induced mouse model of RP. The results of gelatin-zymography analysis demonstrated that MMP-9 expres-
sion and activation was significantly enhanced in MNU-exposed retinas (3.1 ± 0.4-fold) compared with control 
retinas (1.2 ± 0.2-fold; Fig. 7d). Chrysophanol (50 mg/kg) significantly inhibited MNU-induced gelatinolysis 
(1.3 ± 0.1-fold). These results suggested that MMP-9 activity is positively correlated with the pathological cas-
cade of MNU-induced retinal injury. Furthermore, chrysophanol effectively inhibited MMP-9 activation in vivo.
Figure 5. Chrysophanol significantly reduced MNU-induced photoreceptor cell death on day 1. (a) The 
time course of retinal cell death after MNU (60 mg/kg) administration as determined by TUNEL-labeling 
(green dot). The number of apoptotic cells peaked 1 day after the administration of MNU. (b) TUNEL-stained 
sections revealing dead photoreceptors in DAPI-counterstained retinal sections. CTRL: control; GCL: ganglion 
cell layer; INL: inner nuclear layer; ONL: outer nuclear layer.
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Chrysophanol concentration-dependently inhibited lipopolysaccharide (LPS)-induced expression 
of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in BV-2 cells and 
inhibited MMP-9 gelatinolysis in primary microglia. Microglial activation plays a key role in the host 
inflammatory response and contributes to the pathogenesis of retinal degeneration21–23. Accordingly, photore-
ceptor proteins released from RP retinas could activate microglia via Toll-like receptor 4 (TLR4) signaling3,24,25. 
Therefore, we used lipopolysaccharide (LPS), a TLR4 agonist, as an activator to stimulate the microglia cell 
line BV2. LPS (150 ng/mL) significantly increased iNOS and COX-2 protein levels in BV2 microglial cells 
(Fig. 8a), and chrysophanol (0.5–5 μ M) significantly inhibited LPS-induced iNOS and COX-2 expression in a 
concentration-dependent manner. We also examined MMP-9 gelatinolytic activity in LPS-stimulated primary 
microglia (Fig. 8b) and found that MMP-9 activation was significantly induced and activated after LPS stim-
ulation (up to 10.5 ± 0.5-fold) compared with the control group. In addition, chrysophanol significantly and 
concentration-dependently inhibited MMP-9 activation in primary microglia (Fig. 8b).
Discussion
Among the retinal degenerative diseases, RP is hereditarily characterized by progressive rod and cone pho-
toreceptor cell death. In fact, photoreceptor apoptosis is a commonly observed mode of cell death in ocular 
diseases such as RP and age-related macular disease (AMD)26. Therefore, blocking retinal apoptosis might 
delay the progression of RP or AMD27. MNU is a potent retinal toxin that promotes retinal degeneration28. 
Specifically, MNU induces the degeneration of the ONL, a region abundant in photoreceptor cells, and this effect 
Figure 6. Chrysophanol inhibited MNU-induced expression of apoptosis-related proteins. PARP, Bax, 
caspase-3, and p-c-Jun protein levels in retinal homogenates were evaluated using western blot. All the 
Western blotting experiments were performed under the same conditions. After transferring the blots onto 
nitrocellulose membranes, we immediately cropped the targeted blots according to referenced indicating 
markers (Supplementary Fig. S1), and then targeted proteins were immunoblotted with its specific monoclonal 
antibody. The quantification values were presented as the mean ± SEM of at least 3 retinas from each group. 
Representative bands from 2 independent experiments for each group: the control (C1, C2), vehicle-treated 
(V1, V2), and chrysophanol-treated (D1, D2) groups. C, CTRL: control; V: vehicle; D: chrysophanol-treated; N: 
number of animals in each group. #p < 0.01 compared with the control groups treated with vehicle, ##p < 0.001 
compared with the control groups treated with vehicle, *p < 0.01 compared with the MNU-treated group 
treated with vehicle, **p < 0.001 compared with the MNU-treated group treated with vehicle.
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resembles the pathogenesis of end-stage human RP15. The present study was conducted to investigate the poten-
tial anti-apoptotic and retinal-protective effects of chrysophanol in an MNU-induced mouse model of RP. Based 
on the previous studies that evaluated the therapeutic profiles of Cassia seed and chrysophanol in ophthalmic 
and neuroprotective studies9,29, chrysophanol was used at a dose of 50 mg/kg in this study. We demonstrated 
that chrysophanol treatment attenuated photoreceptor cell degeneration and improved scotopic ERG responses 
in MNU-exposed retinas. Notably, chrysophanol effectively restored the integrity and structure of both rod and 
cone photoreceptors 7 days after MNU-induced retinal injury. Moreover, we found that the protective effect of 
chrysophanol in MNU-exposed retinas was mediated by the inhibition of photoreceptor cell apoptosis, prolifer-
ative gliosis, microglial activation, and MMP-9 activation.
A recent study reported that apoptosis-associated DNA fragmentation was observed in rat retinas during 7 
days after MNU exposure30. Consistent with these findings, we observed an increase in TUNEL-labeled apop-
totic cells in the ONL of mouse retinas 1 day after MNU exposure, and chrysophanol significantly abrogated this 
effect. An increase in the expression of apoptotic effectors demonstrated that the DNA adduct formation caused 
by MNU induced poly ADP-ribose polymerase (PARP) activation, further inducing cell death by depleting cel-
lular energy reserves31. PARP has been shown to regulate activator protein-1 (AP-1)32, a dimeric transcription 
factor primarily composed of c-Jun and c-Fos that plays an important role in the regulation of cell proliferation 
and apoptosis33. Previous studies demonstrated that the induction of c-Jun and the phosphorylation of c-Jun at 
its N-terminal are associated with neuronal apoptosis34,35. In the apoptosis cascade, Bax is up-regulated 24 hours 
after the administration of MNU, and cysteine aspartate-specific protease-3 (caspase-3) coordinates and exe-
cutes the apoptotic pathway36,37. A previous study indicated that inhibiting both PARP activity and the JNK/AP-1 
Figure 7. Chrysophanol inhibited MNU-induced reactive gliosis and retinal MMP-9 activation on day 7. 
(a) The time course of GFAP localization (green) after MNU (60 mg/kg) administration. (b) GFAP content in 
DAPI-counterstained retinal sections. (c) MMP-9 gelatinolytic activity in retinal homogenates was detected 
using zymography. All the zymographic experiments were performed under the same conditions. After gelatin 
staining, we immediately cropped the gelatinolytic regions in the gels (Supplementary Fig. S2). The data are 
presented as the mean ± SEM. CTRL: control; V: vehicle; N: number of animals in each group; GCL: ganglion 
cell layer; INL: inner nuclear layer; ONL: outer nuclear layer; IOD: integrated optical density. #p < 0.001 
compared with the control group treated with vehicle, *p < 0.001 compared with the MNU-exposed group 
treated with vehicle.
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signaling pathway blocks MNU-induced photoreceptor cell apoptosis30. Consistent with these findings, we found 
that chrysophanol attenuated the MNU-induced increase in PARP, cleaved PARP, phosphorylated c-Jun, Bax 
and cleaved caspase-3 levels 1 day after the administration of MNU. In summary, our findings suggested that the 
anti-apoptotic effects of chrysophanol were mediated by the inhibition of PARP activation, c-Jun phosphoryla-
tion, and apoptotic effectors.
Nearly all retinal diseases are associated with Müller cell and astrocyte gliosis38,39. The various consequences 
of proliferative gliosis, including the blood-retinal barrier breakdown, antioxidant deficiency, monocyte recruit-
ment, and aggravated neuronal cell death19,40. In the present study, we evaluated the inhibitory effects of chrys-
ophanol on glial cell activation. Glial fibrillary acidic protein (GFAP), a protein that localizes to the end-feet and 
processes of astrocytes and Müller cells, is a biomarker of gliosis in retinal degeneration38,41. In the present study, 
chrysophanol significantly attenuated GFAP overexpression in MNU-exposed retinas.
An increase in matrix metalloproteinase-9 (MMP-9) activity and colocalization of MMP-9 and GFAP have 
been observed in other animal models of retinopathy, such as the optic nerve ligation-induced mouse model of 
retinopathy20. Furthermore, several studies have demonstrated that increased MMP-9 activity plays a critical 
Figure 8. Chrysophanol inhibited iNOS and COX-2 expression and MMP-9 activation in activated 
microglia. (a) Microglial BV2 cells were pretreated with the vehicle (DMSO) or chrysophanol (0.5, 1, 2, and  
5 μ M) and stimulated with LPS (150 ng/ml) for 24 hours. iNOS and COX-2 expression in cell lysates 
was evaluated using western blot. All the Western blotting experiments were performed under the same 
conditions. After transferring the blots onto nitrocellulose membranes, we immediately cropped the targeted 
blots according to referenced indicating markers (Supplementary Fig. S3), and then targeted proteins were 
immunoblotted with its specific monoclonal antibody. (b) Primary microglia cells were pretreated with the 
vehicle (DMSO) or chrysophanol (5, 10, 20, and 50 μ M) and stimulated with LPS (150 ng/mL) for 24 hours. 
MMP-9 activation in cell supernatants was evaluated using zymography. All the zymographic experiments 
were performed under the same conditions. After gelatin staining, we immediately cropped the gelatinolytic 
regions in the gels (Supplementary Fig. S3). The data are presented as the mean ± SEM of at least 3 experiments 
in each group. R: resting; V: vehicle. #p < 0.001 compared with the control group treated with vehicle, *p < 0.01 
compared with the LPS-exposed group treated with vehicle, **p < 0.001 compared with the LPS-exposed group 
treated with vehicle.
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role in neuronal cell death in retinopathies42–44. Therefore, we investigated MMP-9 activity in MNU-exposed 
retinas. As expected, MMP-9 expression and activity significantly increased in MNU-exposed retinas, and this 
phenomenon was inhibited by chrysophanol. Although the inhibitory effect of chrysophanol on MMP-9 activity 
was directly associated with an inhibition of photoreceptor cell apoptosis, a more detailed characterization of this 
correlation requires additional experiments.
Microglia activation is associated with photoreceptor degeneration and subsequent primary rod photore-
ceptor cell death in RP in humans and in mouse models1,3,24. A previous study found that microglia migrate 
to the outer retina and phagocytose rod cell debris1. Photoreceptor proteins released from RP retinas could 
activate microglia via Toll-like receptor 4 (TLR4) signaling, and TLR4-mediated microglial phagoptosis might 
enhance neuronal death by promoting the phagocytosis of injured but living photoreceptors3,24,25. Therefore, we 
used lipopolysaccharide (LPS), a TLR4 agonist, as an activator to stimulate the microglia cell line BV2. In addi-
tion, an increase in the expression of the proinflammatory effectors inducible nitric oxide synthase (iNOS) and 
cyclooxygenase-2 (COX-2), as well as other factors expressed in activated microglia, enhanced photoreceptor 
apoptosis21,23,45,46. A previous clinical study reported that the aqueous humor and levels of serum nitric oxide 
(NO) species are enhanced in RP patients compared with healthy controls, further suggesting that NO exacer-
bates oxidative damage to cone cells in RP47. In this study, we found that chrysophanol significantly inhibited 
LPS-induced iNOS and COX-2 expression in a concentration-dependent manner.
A previous study indicated that down-regulating MMP-9 activity could prevent the apoptotic cell death of 
retinal ganglion cells48. Therefore, we investigated the inhibitory effect of chrysophanol on MMP-9 activation 
in microglia. Consistent with previous findings, we observed that chrysophanol inhibited MMP-9 activation 
in LPS-activated primary microglia in a concentration-dependent manner. Taken together, these findings indi-
cated that chrysophanol effectively inhibited microglia activation by down-regulating inflammatory factors and 
MMP-9 activity and that these effects potentially inhibited disease progression.
In conclusion, we demonstrated that chrysophanol prevented the functional and morphological features of 
MNU-induced retinal degeneration. The retina-protective effects provided by chrysophanol might be mediated 
by the inhibition of apoptosis, proliferative gliosis, microglia activation, and MMP-9 induction. We observed that 
chrysophanol provides neuroprotective effects on retinas, suggesting that chrysophanol might have therapeutic 
value for the treatment of RP and retinal injury. Further studies investigating the precise mechanisms underlying 
the protective and long-term effects associated with chrysophanol are warranted.
Methods
Animals and treatment. Male C57BL/6 mice (25–30 g body weight) were obtained from BioLASCO 
Taiwan Co., Ltd (Taipei, Taiwan) and maintained in a 12 hour light/12 hour dark cycle at 25 ± 1 °C and 39–45% 
relative humidity. Water and food were available ad libitum. All animal procedures were approved by the 
Institutional Animal Care and Use Committee of Taipei Medical University (LAC-2016-0159), and conducted in 
accordance with guidelines of ARVO statement for the use of animals in ophthalmic and vision research.
To characterize MNU-induced retinal degeneration, C57BL/6 mice were intraperitoneally injected with vari-
ous doses of MNU (40, 50, 60, and 70 mg/kg; Chem Service, Westchester, PA, USA) and evaluated at day 1 or day 
7 after the injection. The eyes were rapidly enucleated and processed as described below.
Chrysophanol (50 mg/kg; Sigma, St. Louis, MO) or the vehicle control (0.1% carboxymethyl cellulose) was 
orally administered using a feeding needle. For the 7 day experiments, chrysophanol was delivered daily for 3 
days starting the day before MNU was administered. For the 1 day experiments, a single dose of chrysophanol was 
delivered prior to the administration of MNU.
Scotopic electroretinography (ERG) analysis. Scotopic ERGs were used to evaluate the cone and rod 
photoreceptor responses to light stimulias previously described49. The electroretinography system was composed 
of a MP-36 4-channel amplifier and acquisition system (Biopac Systems, Inc., Pershore, UK) connected to a 
PS33-PLUS photic stimulator (Grass Technologies, Warwick, RI USA). Recordings were obtained using 10 msec 
flash stimuli with an intensity of 16 (19.1 cd · s/m2). ERG a-wave amplitudes were measured from baseline to the 
negative peak, and the b-wave amplitude was measured from the trough of the a-wave to the peak of the positive 
wave. The temporal properties of the ERG response were defined by the time-to-peak (implicit time) of the a- and 
b-wave, and are measured from stimulus onset to the peak of the a- and b-wave. OCT imaging was performed 
immediately after the ERG recording as described below.
Spectral-Domain Optical Coherence Tomography (SD-OCT) imaging. SD-OCT was used to 
non-invasively acquire cross-sectional tomographic images of the retina. This approach allowed for the mon-
itoring of retinal morphology in live experimental animals. The Micron III intraocular imaging system 
(Phoenix Research Labs, Pleasanton, CA), composed of an OCT engine and a scanning lens, was used as pre-
viously described49. The resulting OCT image was imported into the InSight XL software (Phoenix Research 
Laboratories) to measure the total retinal thickness as well as the thickness of the different retinal layers.
Tissue homogenization. All of the animals were euthanized with an injection of a ketamine and xylazine 
mixture, and the eye balls were immediately enucleated. After removing the extraocular tissue, each eye ball was 
transferred into a 2 mL Precellys homogenization tube containing five 2.8-mm ceramic beads (Bertin Technologies, 
Rockville, Maryland) and immersed in 200 μ l of homogenization buffer supplemented with 1× protease inhibi-
tor (Roche, Mannheim, Germany). The samples were homogenized using a tissue homogenizer (Minilys® ; Bertin 
Technologies, Rockville, Maryland) at 5,000 rpm for 30 seconds. The homogenized sample was centrifuged at 5,000 g 
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for 5 min at 4 °C, and the resulting supernatants were incubated at 4 °C for 30 min. The samples were subsequently 
centrifuged at 12,000 g for 20 min at 4 °C and stored at − 80 °C prior to additional experiments.
Immunofluorescence and TUNEL assays. To obtain retinal sections, the mouse eyes were resected 
immediately following transcardial perfusion with 4% paraformaldehyde (PFA) and fixed in Davidson’s fluid at 
4 °C overnight. Then, the eyes were dehydrated with 30% sucrose, frozen-embedded in OCT, and serially sec-
tioned at a thickness of 13 μ m using a cryostat (Cryotome-E; Thermo Shandon, Cheshire, UK). The sections 
were pre-treated with citrate-EDTA buffer (pH 6.2) for epitope retrieval and subsequently incubated in blocking 
solution comprised of 10% normal goat serum and 0.5% Triton X-100 in 0.1 M phosphate buffer (pH 7.4) for 
1 hour. Then, the sections were incubated with anti-GFAP (1:100; ProSci Inc., Poway, CA), anti-rhodopsin (1:50; 
Abcam, Burlingame, CA), and anti-red/green opsin antibody (1:100; Chemicon, Temecula, CA) at 4 °C over-
night. The sections were rinsed and subsequently incubated with the fluorescence-conjugated secondary antibody 
Dylight 488 (1:200; GeneTex, Irvine, CA) for 2 hours at room temperature. Then, the sections were rinsed and 
mounted on cover slips using HIGHDEF® IHC fluoromount (Enzo Life Sciences, Farmingdale, NY) with 2 μ M 
4,6-Diamidino-2-phenylindole (DAPI; AAT Bioquest, Inc., Sunnyvale, CA). DAPI-stained retinal sections were 
used to calculate the number of rows of photoreceptor nuclei in the outer nuclear layer. Three sections nearing the 
central retinal area were counted and averaged in each group, and 3 fields were counted per section. Apoptosis 
was evaluated using the terminal deoxynucleotidyl transferase dUTP nick and labeling (TUNEL) assay as pre-
viously described49 with some modifications. The results of the TUNEL assays are presented as immunofluores-
cence images.
The retinal sections were evaluated using an Eclipse 80i fluorescent microscope (Nikon Instruments, Melville, 
NY) and a Leica TCS SP5 confocal microscope imaging system (Leica Microsystems, Wetzlar, Germany) 
equipped with argon and diode lasers. ImageJ software was used to quantify the number of photoreceptor nuclei 
rows in the ONL and the fluorescence content of GFAP.
Cell culture. The mouse BV-2 microglia cell line was cultured in DMEM supplemented with penicillin 
(90 units/ml), streptomycin (90 μ g/mL), l-glutamine (3.65 mM), HEPES (18 mM), NaHCO3 (23.57 mM), and 10% 
heat-inactivated fetal bovine serum (FBS) at 37 °C in a humidified atmosphere (95% O2, 5% CO2). The cell culture 
conditions and cell treatments have been previously described50.
Isolation of primary microglia. The protocol used to isolate primary microglia was conducted as previ-
ously described with some modifications51. After the rats were perfused, the brain was removed and the meninges 
were resected. The fresh brain tissue was transferred into a dish with 5 mL of 0.25% trypsin (Gibco, Burlington, 
Canada) supplemented with 10 μ g/mL deoxyribonuclease I (Roche, Indianapolis, IN) and minced roughly by 
using scissors. After an incubation period, the brain tissues were further minced with 10 mL of DMEM (Gibco, 
Grand Island, NY) supplemented with 10% FBS, and centrifuged at 1,000 rpm for 10 min. The tissue pellet was 
resuspended in 10% DMEM supplemented with FBS and incubated for the indicated period of time. Microglia 
were harvested from flasks of mixed glial cell cultures shaken for 2 hours, and the cells were collected and pre-
pared for further experiments.
Western blot analysis. Western blot was used to analyze PARP, caspase-3, Bax and p-c-Jun levels in retinal 
homogenates, and iNOS and COX-2 levels in cell lysates as previously described52. The quantitative densitometry 
analysis was conducted using BIO-PROFIL Bio-1D light analytical software (Vilber Lourmat, Marue La Vallee, 
France). Protein levels are presented as the relative intensity compared with the control. The ratio of the optical 
density of the protein product to the internal control (α -tubulin or β -actin) was obtained and was expressed as a 
ratio or percentage of the control value in the Figures.
Gelatin zymography analysis. MMP-9 expression and the activation of retinal homogenates and con-
ditioned medium from cultured primary microglia were evaluated using gelatin zymography as previously 
described53. Clear zones (bands) in a blue background represent MMP-9 degradatory activity. The image was 
acquired using a IP-008-SP Photo-print digital imaging system (Vilber Lourmat, Marue La Vallee, France), and 
BIO-PROFIL Bio-1D light analytical software (Vilber Lourmat, Marue La Vallee, France) was used for the densi-
tometric quantitation of the gelatinolytic zones.
Statistical analyses. The experimental results were expressed as the mean ± SEM from the indicated num-
ber of experiments. The results were analyzed using one-way analysis of variance (ANOVA) with the Sigma Stat 
v3.5 software. The Student-Newman-Keuls test was used to evaluate statistically significant differences between 
groups. A p-value < 0.05 was considered statistically significant.
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